Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy
Status:
Recruiting
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
Open-label, interventional, multicentric, randomized, phase III study. Cancer studied is the
oropharyngeal cancer.
Study is composed by 2 arms of subjects: prophylactic or reactive percutaneous endoscopic
gastrostomy tube placement.
All subjects will be treated with a cisplatin standard chemotherapy regimen and by
simultaneous integrated boost (SIB) intensity modulated radiotherapy (IMRT).